Related Experiment Video
Updated: Jun 28, 2026

06:26
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
Physician-Modified Fenestrated Stent-Grafts Planned Using Three-Dimensional Techniques for Complex Aortic Pathology:
Patryk Skórka1, Karol Miler1, Marta Ziętara1
1Department of Vascular Surgery, Pomeranian Medical University in Szczecin, Szczecin, Poland.
Annals of Vascular Surgery
|June 26, 2026
Summary
Physician-modified stent-grafts (PMSG) planned with 3D techniques offer high technical success and target vessel patency for complex aortic disease. This approach provides a viable alternative when custom devices are unavailable, demonstrating promising outcomes in a meta-analysis.
Area of Science:
- Vascular Surgery
- Medical Imaging
- Interventional Cardiology
Background:
- Complex aortic pathology involving visceral arteries poses significant therapeutic challenges.
- Open repair carries high perioperative risks, especially in comorbid patients.
- Standard EVAR is often limited by inadequate sealing zones, necessitating advanced techniques.
Purpose of the Study:
- To evaluate the effectiveness and safety of physician-modified stent-grafts (PMSG) planned with three-dimensional (3D) techniques.
- To analyze technical success, target vessel patency, early mortality, endoleak, and reintervention rates.
- To assess PMSG as a pragmatic alternative to custom-made fenestrated and branched endovascular repair (F/BEVAR).
Main Methods:
- Systematic search of PubMed/MEDLINE and Embase databases.
- Inclusion of studies using physician-modified fenestrated stent grafts planned with 3D tools.
- Meta-analysis using a random-effects model with logit transformation for proportions.
Main Results:
- Analysis of five studies with 172 patients; mean follow-up of 14.9 months.
- High technical success rate (92.9%) and target vessel patency (96.9%).
- Early mortality was 5.5%, endoleak incidence was 13.3%, and reintervention rate was 6.6%.
Conclusions:
- PMSG procedures planned with 3D techniques demonstrate high technical success and preserved target vessel patency for complex aortic pathology.
- Variability in endoleak and reintervention rates may stem from anatomical complexity and patient selection.
- Further prospective studies are warranted to validate long-term outcomes.